CareFusion has become a wholly-owned subsidiary of BD and will cease trading, and will be de-listed from the New York Stock Exchange. The two companies announced the agreement and plan of merger on Oct. 5, 2014.
“We are very excited to announce the consummation of the CareFusion acquisition, as it represents a major milestone in BD’s 118-year history. This acquisition significantly accelerates BD’s strategy and builds scale and depth in medication management and patient safety solutions,” said Vincent A. Forlenza, BD’s chairman, president and CEO.
More articles on anesthesia:
USAP, Pinnacle partner with Excel Anesthesia
New simulation program leads to anesthesiologist practice improvements, study finds
South Nassau Communities Hospital implements Allscripts anesthesia information solution
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.